Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1104P is a designated human pseudogene related to the U6 small nuclear RNA gene family[1][6][7]. U6 snRNA is a highly conserved non-coding RNA that is a functional component of the spliceosome, the complex responsible for intron removal during mRNA splicing[3][5]. While functional U6 snRNAs have crucial roles in splicing and post-transcriptional mRNA processing, RNU6-1104P itself does not encode functional snRNA nor participate in these processes. Pseudogenes such as RNU6-1104P result from duplication or retrotransposition events; they retain sequence similarity to their parent gene but lack regulatory elements, proper transcription, or functionality[1][6][7]. There is no evidence from current genomic or biomedical databases (GeneCards, NCBI Gene) that this pseudogene is involved in disease, or that its sequence or transcription product serve as a biomarker or therapeutic target[1][6]. While rare pseudogenes can influence gene regulation (usually by acting as competing endogenous RNAs or via epigenetic effects), no such role is documented for RNU6-1104P.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1104, pseudogene (RNU6-1104P).